Perfil
Daniel Kaplan is currently the Chief Scientific Officer at NGM Biopharmaceuticals, Inc. He started this position in 2023.
Prior to his current role, he obtained a doctorate degree from Duke University and an undergraduate degree from the University of California San Diego.
Cargos activos de Daniel Kaplan
| Empresas | Cargo | Inicio |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/04/2023 |
Formación de Daniel Kaplan.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Daniel Kaplan
















